how will fruquintinib fit in the colorectal cancer treatment landscape?
Published 1 year ago • 365 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
2:27
fruquintinib in treating metastatic colorectal cancer
-
3:15
investigating fruquintinib in patients with refractory metastatic crc
-
4:48
fresco-2: phase iii study of fruquintinib in patients with mcrc
-
4:24
dr. cathy eng discusses fresco-2 trial and fruquintinib for colorectal cancer
-
1:24
positive results& remaining questions in the fresco-2 study of colorectal cancer: 2022 esmo florida
-
1:47
new treatment option for metastatic colorectal cancer prolongs survival
-
0:37
is colorectal cancer preventable?
-
24:05
what's new in colorectal cancer treatment? by michael hall, md, ms
-
1:09
futibatinib plus pembrolizumab for the treatment of advanced or metastatic urothelial carcinoma
-
0:27
who gets colon cancer? - dr. john kisiel
-
1:24
fire-4.5: folfoxiri plus either bevacizumab or cetuximab as 1l treatment of braf v600e-mutant mcrc
-
31:04
what's new for colorectal cancer treatment?
-
2:42
paradigm: panitumumab versus bevacizumab in ras-wt mcrc
-
1:40
how can colorectal cancer be prevented?
-
1:00
10 ways to prevent colorectal cancer
-
2:52
the effect of futibatinib on hepatic impairment in icc
-
0:46
prospect: neoadjuvant crt vs folfox in locally advanced rectal cancer
-
14:27
risk factors for colorectal cancer
-
1:46
location matters with colorectal cancer